(Q34003908)

30 July 2017

Younger age as a prognostic indicator in breast cancer: a cohort study (English)

1 reference

30 July 2017

1 reference

Elrasheid H A Kheirelseid

1

1 reference

30 July 2017

Jennifer M E Boggs

2

1 reference

30 July 2017

Catherine Curran

3

1 reference

30 July 2017

Ronan W Glynn

4

1 reference

30 July 2017

Cara Dooley

5

1 reference

30 July 2017

Karl J Sweeney

6

1 reference

30 July 2017

Michael J Kerin

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

28 August 2011

1 reference

30 July 2017

1 reference

30 July 2017

11

1 reference

30 July 2017

383

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-383

30 July 2017

0 references

cites work

An Algorithm for Optimal Tapered Matching, With Application to Disparities in Survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Breast radiotherapy for occult breast cancer with axillary nodal metastases--does it reduce the local recurrence rate and increase overall survival?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Breast cancer in women under 40 years of age: a series of 57 cases from Northern Ireland

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Recent trends in breast cancer among younger women in the United States

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Basal-like breast cancer: a critical review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Adjuvant therapy of the very young woman

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

The preferred treatment for young women with breast cancer--mastectomy versus breast conservation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Study of time-course changes in annual recurrence rates for breast cancer: data analysis of 2,209 patients for 10 years post-surgery

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Global cancer statistics, 2002

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Early-onset breast cancer--histopathological and prognostic considerations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Breast cancer in young women: clinicopathological features and biological specificity

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Breast cancer in young women: poor survival despite intensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Do young breast cancer patients have worse outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Patient and tumor characteristics associated with increased mortality in young women (< or =40 years) with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Breast cancer in young Asian women: study on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Breast radiotherapy: considerations in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

The 2000 EBCTCG overview: a widening gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-383

The impact of young age on breast cancer outcome.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184119

Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy

29 October 2018

1 reference

12 December 2020

Overview of randomized trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation

1 reference

12 December 2020

Breast cancer in Chinese women younger than age 40: are they different from their older counterparts?

1 reference

12 December 2020

Prognostic significance of young age in breast cancer

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Stage 0 to stage III breast cancer in young women

1 reference

12 December 2020

Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group

1 reference

12 December 2020

Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status

1 reference

12 December 2020

Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features

1 reference

12 December 2020

Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment

1 reference

12 December 2020

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Breast carcinoma in young patients

1 reference

12 December 2020

Improved survival in young women with breast cancer

1 reference

12 December 2020

More evidence that locoregional radiation therapy improves survival: what should we do?

1 reference

12 December 2020

Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Long-term outcome in women less than 30 years of age with breast cancer

1 reference

12 December 2020

Younger women with breast carcinoma have a poorer prognosis than older women

1 reference

12 December 2020

Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-11-383

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference